Evaxion Biotech A/S (EVAX) Earnings Date, Estimates & Call Transcripts $1.38 -0.05 (-3.50%) (As of 12/5/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Evaxion Biotech A/S Latest Earnings SummaryActual EPS (Oct. 31) -$0.04 Beat By $0.08 Consensus EPS (Oct. 31) -$0.12 Evaxion Biotech A/S posted Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.04, which beat the consensus estimate of -$0.12 by $0.08. Quarterly revenue was reported to be $3.02 million, above analysts' expectations of $0.19 million. With a trailing EPS of -$0.29, Evaxion Biotech A/S's earnings are expected to grow next year, from ($0.15) to ($0.11) per share. Conference Call TranscriptPowered by Get Evaxion Biotech A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evaxion Biotech A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEVAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EVAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Evaxion Biotech A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241$0.02$0.02$0.02Q3 20241-$0.12-$0.12-$0.12Q4 20241-$0.12-$0.12-$0.1220243-$0.22-$0.22-$0.22Q1 20251-$0.12-$0.12-$0.12Q2 20251-$0.12-$0.12-$0.12Q3 20251-$0.13-$0.13-$0.13Q4 20251-$0.10-$0.10-$0.10FY 20254-$0.47-$0.47-$0.47Q1 20261-$0.10-$0.10-$0.10Q2 20261-$0.11-$0.11-$0.11 Evaxion Biotech A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/31/2024Q3 2024-$0.12-$0.04+$0.08-$0.04$0.19M$3.02M8/14/2024Q2 2024$0.02-$0.12 -$0.14-$0.12$0.10M$0.15M5/28/2024Q1 2024-$0.03+$0.03$0.03-$0.05M3/27/2024Q4 2023--$0.16 -$0.16-$0.16-$0.07M12/19/2023Q3 2023-$1.90-$2.10 -$0.20-$0.21--8/22/2023Q2 2023-$2.20-$2.10+$0.10-$0.21-- Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 5/31/2023Q1 2023-$2.60-$2.40+$0.20-$0.24--4/27/2023Q4 2022--$2.90 -$2.90-$0.29-- Evaxion Biotech A/S Earnings - Frequently Asked Questions When did Evaxion Biotech A/S announce their last quarterly earnings? Evaxion Biotech A/S (NASDAQ:EVAX) last announced its quarterly earning data on Thursday, October 31, 2024. Learn more on EVAX's earnings history. Did Evaxion Biotech A/S beat their earnings estimates last quarter? In the previous quarter, Evaxion Biotech A/S (NASDAQ:EVAX) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.08. Learn more on analysts' earnings estimate vs. EVAX's actual earnings. How can I read Evaxion Biotech A/S's conference call transcript? The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online. Read Transcript How much revenue does Evaxion Biotech A/S generate each year? Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded annual revenue of $70,000.00. How much profit does Evaxion Biotech A/S generate each year? Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded net income of -$22.12 million. EVAX has generated -$0.29 earnings per share over the last four quarters. What is Evaxion Biotech A/S's EPS forecast for next year? Evaxion Biotech A/S's earnings are expected to grow from ($0.15) per share to ($0.11) per share in the next year. More Earnings Resources from MarketBeat Related Companies Pluri Earnings MiNK Therapeutics Earnings Calidi Biotherapeutics Earnings SAB Biotherapeutics Earnings CERo Therapeutics Earnings Athira Pharma Earnings IN8bio Earnings Finch Therapeutics Group Earnings Cyclo Therapeutics Earnings Cognition Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. This page (NASDAQ:EVAX) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredRevenues are rocking prompting a bullish price target of $32.50!“This Biotech Company is worth paying attention to,” says Zack’s SCR, who recently lifted its price target sha...Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.